IN-VITRO STUDY OF Α- GLUCOSIDASE INHIBITION ACTIVITY OF ALSTONIA SCHOLARIS AND CATHARANTHUS ROSEUS
Open Access
- 31 December 2022
- journal article
- research article
- Published by Gujarat University in VIDYA - A JOURNAL OF GUJARAT UNIVERSITY
- Vol. 1 (2) , 88-95
Abstract
The increasing population of Diabetes Mellitus (DM) in the world has always been concerned by physicians and scientists due to its life-threatening effects including heart diseases and premature death. Out of them, nearly 90-95% population is having type 2 diabetes mellitus (T2DM), characterised by insulin resistance. The available treatments for T2DM includes inhibition of α- glucosidase present on the brush border of human intestine that controls post-prandial hyperglycaemia by slower the releasing of glucose in the blood. Adverse effects of the available α- glucosidase inhibitors (AGI) such as abdominal discomfort and hypoglycaemia has prompted a search for the newer AGIs from natural compounds. The impact of various plant extracts on the management of medical disorders has recently aroused curiosity of researchers. Alstonia scholaris has set its hight reputation in ethnopharmacological world for treating major health issues including skin carcinoma, lung cancer and also T2DM. Though some research supports the antidiabetic activity of the plant, the mode of action responsible for it has yet to be discovered. At the same time, Catharanthus roseus has also been proved to be effective in diabetic conditions but in vitro study of antidiabetic activity of the plant is yet to be encountered. The presented study investigated different extracts of A. scholaris and C. roseus on α- glucosidase isolated from Saccharomyces cerevisiae. The presented research not only gives in-vitro proves of the plants as AGIs but also open ups new pathways in understanding the secondary metabolites as inhibitors.Keywords
This publication has 25 references indexed in Scilit:
- Antidiabetic and hepatoprotective potential of whole plant extract and isolated compounds of Aeginetia indicaBiomedicine & Pharmacotherapy, 2020
- In silico screening of potential antidiabetic phytochemicals from Phyllanthus emblica against therapeutic targets of type 2 diabetesJournal of Ethnopharmacology, 2020
- Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataractJournal of Integrative Medicine, 2019
- New α-Glucosidase inhibitors from the resins of Boswellia species with structure–glucosidase activity and molecular docking studiesBioorganic Chemistry, 2018
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045Diabetes Research and Clinical Practice, 2018
- Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacologyJournal of Ethnopharmacology, 2014
- Antidiabetic and antihyperlipidemic activity of leaves of Alstonia scholaris Linn. R.Br.,European Journal of Integrative Medicine, 2010
- α-Glucosidase inhibitors from Devil tree (Alstonia scholaris)Food Chemistry, 2007
- Evaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (Sapthaparna) in vitro and in vivoPhytotherapy Research, 2006
- Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitusThe American Journal of Medicine, 1995